CORRECTION article

Front. Pharmacol., 27 February 2023

Sec. Integrative and Regenerative Pharmacology

Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1148908

Corrigendum: Bushen huoxue decoction inhibits RANKL-stimulated osteoclastogenesis and glucocorticoid-induced bone loss by modulating the NF-κB, ERK, and JNK signaling pathways

  • 1. School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, China

  • 2. Laboratory of Orthopedics and Traumatology, Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China

  • 3. School of Chinese Herbal Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China

  • 4. The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

  • 5. Department of Traumatology, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

Article metrics

View details

3

Citations

1,1k

Views

726

Downloads

In the published article, there was an error in Figure 5 as published. In Figure 5E, the position of the experimental images of DEX group and DEX + BHD group is inverted, that is, the images of DEX group should appear in DEX + BHD group, while the images of DEX + BHD group should appear in DEX group. The corrected Figure 5 and its caption appear below.

FIGURE 5

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

bushen huoxue decoction, osteoporosis, NF-κB pathway, ERK pathway, JNK pathway

Citation

Liu Y, Fu B, Li X, Chen C, Li X, Xu L and Wang B (2023) Corrigendum: Bushen huoxue decoction inhibits RANKL-stimulated osteoclastogenesis and glucocorticoid-induced bone loss by modulating the NF-κB, ERK, and JNK signaling pathways. Front. Pharmacol. 14:1148908. doi: 10.3389/fphar.2023.1148908

Received

20 January 2023

Accepted

17 February 2023

Published

27 February 2023

Volume

14 - 2023

Edited and reviewed by

Chang-Hee Suh, Ajou University, Republic of Korea

Updates

Copyright

*Correspondence: Bin Wang, ; Liangliang Xu,

†These authors have contributed equally to this work and share first authorship

This article was submitted to Integrative and Regenerative Pharmacology, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics